Dr. Dustin G. Mark, MD

Dr. Mark practices at Addiction Medicine & Recovery Services at Oakland Medical Center in Oakland, California.

Dr. Mark's NPI, 1881755270, was assigned on December 12, 2006. Dr. Mark graduated from UCSF School of Medicine in 2004. Dr. Mark holds California license A107858.

Dr. Mark's primary practice is Addiction Medicine & Recovery Services at Oakland Medical Center, at 380 West MacArthur Boulevard, Oakland, CA 94609. The practice phone is (510) 251-0121.

Dr. Mark's primary practice is Addiction Medicine & Recovery Services at Oakland Medical Center in Oakland, California. Dr. Mark is also affiliated with Oakland Medical Center. The medical group on file is The Permanente Medical Group, Inc.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mark practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Mark's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Mark is board certified in anesthesiology critical care medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Mark's licenses on file in 2 states: California and Pennsylvania.

CMS data shows 48 Medicare services from Dr. Mark across 2 procedure codes in 2024, for 70 Medicare patients. Medicare paid $5,219 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Mark in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 79% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mark's median patient age at 50, with 52% women.

In 2024, Dr. Mark wrote 168 Medicare Part D claims for 99 patients. 90% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $157 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Mark accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 74 papers to Dr. Mark, published from 2009 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Emergency Service, Hospital, California and Decision Support Systems, Clinical. Dr. Mark has published most often in Am J Emerg Med. Dr. Mark's most frequent co-authors are David R. Vinson, MD, Uli Kumar Chettipally, MD and Dana R. Sax, MD.

Dmand AI links Dr. Mark to 1 clinical trial. Conditions studied include Risk Reduction Behavior and Acute Coronary Syndrome.

CMS Open Payments shows 1 general payment to Dr. Mark from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $23.

Dr. Mark graduated from UCSF School of Medicine in 2004.

Dr. Mark is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.